Egashira N - Search Results

1

Risk Factor for Rash in Patients Receiving Cytarabine and Idarubicin Induction Therapy for Acute Myeloid Leukemia.

Uchida M, Ishida S, Mochizuki E, Ozawa N, Yonemitsu H, Ochiai H, Nakamura H, Kawashiri T, Watanabe H, Tsuji T, Suetsugu K, Kato K, Egashira N, Akashi K, Ieiri I. Uchida M, et al. Among authors: egashira n. Cancer Diagn Progn. 2024 Sep 1;4(5):617-622. doi: 10.21873/cdp.10372. eCollection 2024 Sep-Oct. Cancer Diagn Progn. 2024. PMID: 39238617 Free PMC article.

2

Usefulness of a Medication Instruction Sheet for Patients Receiving Cytarabine and Idarubicin Induction Therapy for Acute Myeloid Leukemia.

Uchida M, Mochizuki E, Ishida S, Ozawa N, Yonemitsu H, Ochiai H, Nakamura H, Kawashiri T, Kato K, Egashira N, Akashi K, Ieiri I. Uchida M, et al. Among authors: egashira n. In Vivo. 2023 Mar-Apr;37(2):924-932. doi: 10.21873/invivo.13164. In Vivo. 2023. PMID: 36881060 Free PMC article.

3

Development of Real-world Data-based Medication Instruction Sheet for Acute Myeloid Leukemia Patients Receiving High-dose Cytarabine Consolidation Therapy.

Uchida M, Ishida S, Mochizuki E, Ozawa N, Yonemitsu H, Ochiai H, Nakamura H, Kawashiri T, Kato K, Egashira N, Akashi K, Ieiri I. Uchida M, et al. Among authors: egashira n. Anticancer Res. 2023 Jul;43(7):3321-3329. doi: 10.21873/anticanres.16508. Anticancer Res. 2023. PMID: 37351973

4

Risk Factors for Gemcitabine-Induced Vascular Pain in Patients With Pancreatic Cancer.

Ishida S, Makihara Y, Watanabe H, Nakashima T, Nagata K, Suetsugu K, Tsuji T, Hata K, Ikeda M, Ikebe M, Minami H, Watanabe H, Nakata K, Nakamura M, Egashira N, Ieiri I. Ishida S, et al. Among authors: egashira n. Ann Pharmacother. 2021 Jun;55(6):738-744. doi: 10.1177/1060028020969354. Epub 2020 Oct 23. Ann Pharmacother. 2021. PMID: 33094647

5

Prognostic significance of pre-treatment ALBI grade in advanced non-small cell lung cancer receiving immune checkpoint therapy.

Matsukane R, Watanabe H, Hata K, Suetsugu K, Tsuji T, Egashira N, Nakanishi Y, Okamoto I, Ieiri I. Matsukane R, et al. Among authors: egashira n. Sci Rep. 2021 Jul 23;11(1):15057. doi: 10.1038/s41598-021-94336-9. Sci Rep. 2021. PMID: 34301991 Free PMC article.

6

Usefulness of Medication Guidance Sheets for Patients With Non-Hodgkin's Lymphoma Receiving ESHAP±R Therapy.

Uchida M, Murata S, Morikawa H, Yonemitsu H, Ishida S, Suetsugu K, Tsuji T, Watanabe H, Kawashiri T, Kato K, Hosohata K, Miyamoto T, Egashira N, Nakamura T, Akashi K, Ieiri I. Uchida M, et al. Among authors: egashira n. Anticancer Res. 2022 Apr;42(4):2053-2060. doi: 10.21873/anticanres.15686. Anticancer Res. 2022. PMID: 35347028

7

Evaluation of Medication Instruction Sheets for Patients Undergoing R-CHOP Therapy in Non-Hodgkin's Lymphoma.

Uchida M, Kawai R, Hisamitsu R, Mai S, Ishida S, Watanabe H, Kawashiri T, Kato K, Hosohata K, Miyamoto T, Egashira N, Nakamura T, Akashi K, Ieiri I. Uchida M, et al. Among authors: egashira n. In Vivo. 2022 May-Jun;36(3):1461-1467. doi: 10.21873/invivo.12852. In Vivo. 2022. PMID: 35478137 Free PMC article.

8

Improvement of Medication Guidance Sheet for Total Body Irradiation/Cyclophosphamide Followed by Allogeneic Hematopoietic Stem Cell Transplantation Based on Real Monitoring Data.

Uchida M, Ishida S, Mochizuki E, Ozawa N, Yonemitsu H, Ochiai H, Nakamura H, Kawashiri T, Kato K, Egashira N, Akashi K, Ieiri I. Uchida M, et al. Among authors: egashira n. Anticancer Res. 2023 Sep;43(9):4067-4075. doi: 10.21873/anticanres.16596. Anticancer Res. 2023. PMID: 37648335

9

Detection of overdose and underdose prescriptions-An unsupervised machine learning approach.

Nagata K, Tsuji T, Suetsugu K, Muraoka K, Watanabe H, Kanaya A, Egashira N, Ieiri I. Nagata K, et al. Among authors: egashira n. PLoS One. 2021 Nov 19;16(11):e0260315. doi: 10.1371/journal.pone.0260315. eCollection 2021. PLoS One. 2021. PMID: 34797894 Free PMC article.

10

Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving multiday chemotherapy.

Uchida M, Ikesue H, Kato K, Ichinose K, Hiraiwa H, Sakurai A, Takenaka K, Iwasaki H, Miyamoto T, Teshima T, Egashira N, Akashi K, Oishi R. Uchida M, et al. Among authors: egashira n. Am J Health Syst Pharm. 2013 Feb 15;70(4):343-9. doi: 10.2146/ajhp120363. Am J Health Syst Pharm. 2013. PMID: 23370141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters